GlassScriptPhysician profile
Michael Rodriguez
NPI 1528356284
$8,507.20
in general payments reported to CMS, 2019-2025
34 companies · $1,597 in 2025
The $1,597 reported for 2025 was more than what 89% of Otolaryngology/Facial Plastic Surgery providers received nationally (typical 2025 total: $305).
See the full distribution for Otolaryngology/Facial Plastic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $980 · 2020: $211 · 2021: $952 · 2022: $1,274 · 2023: $1,489 · 2024: $2,004 · 2025: $1,597.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,573 · Consulting Fee: $407 · Education: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,572.90 |
| Consulting Fee | $406.70 |
| Education | $110.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $1,488.61 | 2019-2025 | |
| Medtronic, INC. | $1,474.44 | 2021-2025 | Nuvent, Fusion, Stealthstation S8 Platform |
| Inspire Medical Systems, INC. | $782.41 | 2022-2025 | Inspire |
| Aerin Medical INC. | $680.08 | 2019-2025 | |
| Genzyme Corporation | $660.01 | 2019-2025 | |
| Glaxosmithkline, LLC. | $654.80 | 2021-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $613.53 | 2019-2025 | Dupixent |
| Intersect Ent, INC. | $560.04 | 2019-2021 | |
| Stryker Corporation | $245.96 | 2020-2025 | Audion Et Dilation System, Xpress Loprofile |
| Kaleo, INC. | $219.72 | 2021-2023 | Auvi-Q |
| Medtronic USA, INC. | $213.81 | 2019-2020 | |
| Integra Lifesciences Corporation | $180.46 | 2024 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Sanofi-Aventis U.S. LLC | $70.13 | 2021-2024 | |
| Cochlear Americas | $62.16 | 2023-2024 | Osia Osi300 Implant, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha |
| Acclarent, INC | $53.25 | 2019-2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $46.09 | 2019-2025 | |
| Covis Pharma Gmbh | $45.32 | 2021 | |
| Novartis Pharmaceuticals Corporation | $43.38 | 2021 | |
| Dilon Technologies, INC. | $40.74 | 2023 | Hemoblast Bellows |
| Ars Pharmaceuticals Operations, INC. | $38.42 | 2025 | Neffy |
| Jubilant Hollisterstier LLC | $37.40 | 2020-2021 | |
| Biom'Up France Sas | $37.07 | 2021 | |
| Smith+Nephew, INC. | $36.84 | 2021-2024 | Halo, Tula |
| Acacia Pharma INC | $31.93 | 2022 | |
| Zoll Respicardia, INC. | $23.82 | 2023 | Remede System |
| Uswm, LLC | $22.00 | 2021 | |
| Alk-Abello, INC | $21.59 | 2021 | |
| Neurent Medical Limited | $21.59 | 2025 | Neuromark System, Neuromark Radiofrequency Console |
| Takeda Pharmaceuticals U.S.A., INC. | $21.33 | 2024 | Hyqvia |
| Amgen INC. | $19.98 | 2025 | Tezspire |
| Hikma Pharmaceuticals USA | $18.72 | 2023 | Ryaltris |
| Ambu INC. | $17.82 | 2024 | |
| Acelrx Pharmaceuticals, INC. | $12.14 | 2022 | |
| Phadia US INC. | $11.61 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.